Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-27

FDA Approved: HYCODAN — Supplemental Application (Genus Lifesciences Inc.)

View source ↗

Summary

The FDA granted a supplemental approval for HYCODAN, a hydrocodone bitartrate and homatropine methylbromide combination product from Genus Lifesciences Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYCODAN (HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE)

Snippet

SUPPL AP for HYCODAN (HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE)